### ü´† Valvular Heart Disease: Chronic Severe Aortic Regurgitation

#### ‚úÖ True Statements
1. In chronic **aortic regurgitation**, **aortic valve replacement (AVR)** is advised for patients with **symptoms**, most typically **dyspnea** or **angina**.
2. **Aortic valve replacement** is indicated in chronic **aortic regurgitation** when **left ventricular ejection fraction (LVEF)** is **‚â§55%** and no other cause of dysfunction is present.
3. **Aortic valve replacement** is also recommended in patients with **severe aortic regurgitation** who are undergoing **other cardiac surgery**.
4. Surgical treatment is reasonable in **asymptomatic** patients with **severe aortic regurgitation**, **normal LVEF**, and **significant left ventricular (LV) dilatation**.
5. **Significant LV dilatation** in the context of aortic regurgitation is defined as **LV end-systolic diameter >50 mm** or **indexed end-systolic dimension >25 mm/m¬≤**.
6. **Transcatheter aortic valve implantation (TAVI)** is **not currently indicated** for the treatment of **aortic regurgitation**.
7. In **chronic aortic regurgitation** with **concomitant hypertension**, preferred medical therapy includes **dihydropyridine calcium channel blockers**, **angiotensin-converting enzyme (ACE) inhibitors**, or **angiotensin receptor blockers (ARBs)**.
8. **Medical therapy** for hypertension does **not eliminate the need for surgery** in patients with **severe aortic regurgitation** when surgical criteria are met.
9. For **asymptomatic** patients with **severe aortic regurgitation**, **normal LVEF**, and **no LV dilation**, **monitoring** with **clinical evaluation** and **echocardiography every 6 to 12 months** is appropriate.

#### üí¨ Extra
1. Symptoms in chronic aortic regurgitation usually develop late and may include exertional dyspnea or anginal chest pain.
2. AVR in this setting prevents irreversible LV dysfunction and adverse outcomes.
4. LV dilation is used as a surrogate for impending LV dysfunction in asymptomatic patients.
6. TAVI devices lack sufficient radial force to secure in noncalcified aortic roots typical of aortic regurgitation.
7. These medications reduce afterload and may slow LV dilation.
9. Serial imaging ensures timely identification of LV enlargement or dysfunction.

#### üî∑ Tags
#Cardiology #ValvularHeartDisease #AorticRegurgitation #AorticValveReplacement #AmbulatoryCare

#### üìô Reference
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. *Circulation*. 2021;143:e72-e227. PMID: 33332150 doi:10.1161/CIR.0000000000000923

#### üÜî Question ID
CVMCQ24122

#### üïí Last Updated
January 2025

#### üìñ Related Text  
MKSAP 19: Cardiovascular Medicine ‚Äî Valvular Heart Disease, Aortic Regurgitation, Clinical Presentation and Evaluation

---

### üìò Related Text Derivations

#### ‚úÖ True Statements
1. **Aortic regurgitation** arises from either **aortic root pathology** or **intrinsic aortic valve disease**.
2. Causes of **chronic aortic regurgitation** include **ascending aortic dilatation**, **bicuspid valve disease**, **calcific degeneration**, **rheumatic involvement**, and **chest irradiation**.
3. Causes of **acute aortic regurgitation** include **aortic dissection**, **infective endocarditis**, **blunt chest trauma**, and **iatrogenic damage** (e.g., balloon aortic valvuloplasty).
4. In **chronic aortic regurgitation**, **volume overload** leads to **left ventricular (LV) dilatation** and **eccentric hypertrophy**.
5. Symptoms of **chronic aortic regurgitation** include **shortness of breath**, **fatigue**, and **angina**.
6. Physical findings in **chronic aortic regurgitation** may include **bounding peripheral pulses**, **displaced LV apex**, and a **diastolic decrescendo murmur**.
7. A **diastolic decrescendo murmur** in aortic regurgitation may be heard along the **right sternal border** (suggesting root pathology) or **left sternal border** (suggesting valve pathology).
8. A **systolic ejection murmur** may also be heard in **chronic aortic regurgitation** due to the **large forward stroke volume**.
9. In **acute aortic regurgitation**, bounding pulses may be absent and murmurs softer or shorter due to **rapid pressure equalization** between the aorta and LV.
10. **Transthoracic echocardiography (TTE)** is indicated for the evaluation of **aortic regurgitation** and **LV function**.
11. If TTE is suboptimal or discordant with clinical findings, further evaluation may include **transesophageal echocardiography (TEE)**, **cardiac magnetic resonance (CMR) imaging**, or **cardiac catheterization**.
12. Criteria for **severe aortic regurgitation** include:
    - Jet width occupying ‚â•65% of the LV outflow tract
    - **Vena contracta** >0.6 cm
    - **Holodiastolic flow** in the descending aorta
    - **Regurgitant volume** ‚â•60 mL
    - **Effective regurgitant orifice area** ‚â•0.3 cm¬≤
13. The **left ventricle** is typically **dilated** in patients with **chronic aortic regurgitation**.
14. In suspected **aortic root abnormalities**, evaluation with **CMR imaging**, **CT**, or **TEE** is recommended.
15. In **acute aortic regurgitation** with **aortic dissection**, **CT angiography** is indicated due to its high accuracy and rapid availability.
16. **Surveillance** of patients with **aortic regurgitation** depends on the **severity of regurgitation** and other clinical factors.

#### üí¨ Extra
1. Aortic root pathology includes dilation of the ascending aorta or sinuses of Valsalva, while intrinsic valve disease includes leaflet abnormalities.
2. These chronic etiologies tend to progress slowly, allowing adaptive LV remodeling before symptoms develop.
3. Iatrogenic damage may occur during cardiac procedures that involve the aortic valve.
4. Eccentric hypertrophy maintains cardiac output for some time before symptoms emerge.
6. Bounding pulses are due to wide pulse pressure from increased stroke volume and low diastolic pressure.
9. Rapid equalization of diastolic pressures reduces murmur duration and intensity.
11. Each modality offers advantages: CMR for quantification, TEE for visualization, catheterization for hemodynamics.
12. These are standard echocardiographic and Doppler criteria used to define severe regurgitation.
15. CT is preferred over MRI in emergencies due to speed and availability.

#### üî∑ Tags
#Cardiology #ValvularHeartDisease #AorticRegurgitation #Echocardiography #CMR #TTE #TEE #HeartMurmurs #AorticRootPathology

---

#### üé• Supplemental Video

<figure>
  <video controls src="Chronic Aortic Regurgitation.mp4" width="100%"></video>
  <figcaption>
    <strong>Chronic Aortic Regurgitation</strong><br>
    The carotid pulse is bisferiens with a brisk upstroke. In the aortic area, there is a high-frequency grade 2, diastolic decrescendo murmur. The murmur begins with A2 and then diminishes in intensity.<br>
    Video used with permission from the Michael S. Gordon Center for Simulation and Innovation in Medical Education, University of Miami Miller School of Medicine, Miami, Florida. <a href="https://gordoncenter.miami.edu" target="_blank">https://gordoncenter.miami.edu</a>
  </figcaption>
</figure>

---

### üìä Supplemental Tables

<!-- Serial Evaluation of Asymptomatic Patients With Left-Sided Valvular Conditions -->
<table>
  <caption><strong>Serial Evaluation of Asymptomatic Patients With Left-Sided Valvular Conditions</strong></caption>
  <thead>
    <tr>
      <th>Condition</th>
      <th>Factors Considered</th>
      <th>VHD Stage</th>
      <th>Lesion Severity</th>
      <th>Frequency of Evaluation</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td rowspan="4"><strong>Aortic Stenosis</strong></td>
      <td rowspan="4">Stenosis severity; rate of progression; LV systolic function; ascending aorta dilation if associated with bicuspid aortic valve</td>
      <td>A</td>
      <td>At risk (V<sub>max</sub> &lt;2 m/s)</td>
      <td>‚Äî</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Mild (V<sub>max</sub> 2.0‚Äì2.9 m/s or mean gradient &lt;20 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 3‚Äì5 y</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Moderate (V<sub>max</sub> 3.0‚Äì3.9 m/s or mean gradient 20‚Äì39 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 1‚Äì2 y</td>
    </tr>
    <tr>
      <td>C1</td>
      <td>Severe (V<sub>max</sub> ‚â•4 m/s or mean gradient ‚â•40 mm Hg, AVA typically ‚â§1.0 cm¬≤)<br>Very severe (V<sub>max</sub> ‚â•5 m/s or mean gradient ‚â•60 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 6‚Äì12 mo</td>
    </tr>
    <tr>
      <td rowspan="3"><strong>Aortic Regurgitation</strong></td>
      <td rowspan="3">Regurgitation severity; rate of progression; LV ejection fraction; LV chamber size; ascending aorta dilation if bicuspid aortic valve</td>
      <td>B</td>
      <td>Mild (VC &lt;0.3 cm, ERO &lt;0.10 cm¬≤, RV &lt;30 mL/beat, RF &lt;30%); normal EF</td>
      <td>Clinical evaluation yearly; echo every 3‚Äì5 y</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Moderate (VC 0.3‚Äì0.6 cm, ERO 0.10‚Äì0.29 cm¬≤, RV 30‚Äì59 mL/beat, RF 30%‚Äì49%)</td>
      <td>Clinical evaluation yearly; echo every 1‚Äì2 y</td>
    </tr>
    <tr>
      <td>C1</td>
      <td>Severe (VC &gt;0.6 cm, ERO ‚â•0.3 cm¬≤, RV ‚â•60 mL/beat, RF ‚â•50%)</td>
      <td>Clinical evaluation every 6‚Äì12 mo; echo every 6‚Äì12 mo, more frequently for dilating LV</td>
    </tr>
    <tr>
      <td rowspan="2"><strong>Mitral Stenosis</strong></td>
      <td rowspan="2">Stenosis severity</td>
      <td>B</td>
      <td>Mild and moderate (MVA &gt;1.5 cm¬≤, diastolic pressure half-time &lt;150 ms)</td>
      <td>Clinical evaluation yearly; echo every 3‚Äì5 y</td>
    </tr>
    <tr>
      <td>C1</td>
      <td>Severe (MVA 1.0‚Äì1.5 cm¬≤, diastolic pressure half-time ‚â•150 ms or ‚â•220 ms with very severe stenosis, PASP &gt;50 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 1‚Äì2 y for MVA 1.0‚Äì1.5 cm¬≤, every year for MVA &lt;1.0 cm¬≤</td>
    </tr>
    <tr>
      <td rowspan="3"><strong>Mitral Regurgitation</strong></td>
      <td rowspan="3">Regurgitation severity; rate of progression; EF; LV chamber size</td>
      <td>A</td>
      <td>Mild (VC &lt;0.3 cm, ERO &lt;0.2 cm¬≤, RV &lt;30 mL/beat, RF &lt;30%)</td>
      <td>Clinical evaluation yearly; echo every 3‚Äì5 y</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Moderate (VC &lt;0.7 cm, ERO 0.2‚Äì0.39 cm¬≤, RV 30‚Äì59 mL/beat, RF 30%‚Äì49%)</td>
      <td>Clinical evaluation yearly; echo every 1‚Äì2 y</td>
    </tr>
    <tr>
      <td>C</td>
      <td>Severe (VC ‚â•0.7 cm, ERO ‚â•0.4 cm¬≤, RV ‚â•60 mL/beat, RF ‚â•50%)</td>
      <td>Clinical evaluation every 6‚Äì12 mo; echo every 6‚Äì12 mo, more frequently for dilating LV</td>
    </tr>
  </tbody>
</table>

<p><em>
AVA = aortic valve area; echo = echocardiography; EF = ejection fraction; ERO = effective regurgitant orifice; LV = left ventricular; LVESD = left ventricular end-systolic dimension; MVA = mitral valve area; PASP = pulmonary artery systolic pressure; RF = regurgitant fraction; RV = regurgitant volume; VC = vena contracta width; VHD = valvular heart disease; V<sub>max</sub> = maximum aortic jet velocity.
</em></p>

<p><strong>Reference:</strong> Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2021;77:e25‚Äìe197. <a href="https://doi.org/10.1016/j.jacc.2020.11.018">doi:10.1016/j.jacc.2020.11.018</a> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33342586">33342586</a>
</p>

---

<!-- Valvular and Other Cardiac Lesions and Their Associated Examination Findings -->
<table>
  <caption><strong>Valvular and Other Cardiac Lesions and Their Associated Examination Findings</strong></caption>
  <thead>
    <tr>
      <th>Cardiac Condition</th>
      <th>Characteristic Murmur</th>
      <th>Location</th>
      <th>Radiation</th>
      <th>Associated Findings</th>
      <th>Severity and Pitfalls</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Aortic stenosis</td>
      <td>Midsystolic; crescendo-decrescendo</td>
      <td>RUSB</td>
      <td>Right clavicle, carotid; apex</td>
      <td>Enlarged, nondisplaced apical impulse; S‚ÇÑ; bicuspid valve without calcification will have systolic ejection click followed by murmur</td>
      <td>Severe aortic stenosis findings may include decreased A‚ÇÇ; high-pitched, late-peaking murmur; diminished and delayed carotid upstroke; radiation of murmur to both clavicles and carotids. Radiation of murmur down the descending thoracic aorta may mimic mitral regurgitation</td>
    </tr>
    <tr>
      <td>Aortic regurgitation</td>
      <td>Diastolic; decrescendo</td>
      <td>LLSB (valvular) or RLSB (dilated aortic root) (best heard sitting and leaning forward)</td>
      <td>None</td>
      <td>Enlarged, displaced apical impulse; S‚ÇÉ or S‚ÇÑ; increased pulse pressure; bounding carotid and peripheral pulses</td>
      <td>Acute severe regurgitation murmur may be masked by tachycardia and short duration of murmur. Severity in chronic regurgitation is difficult to assess by auscultation</td>
    </tr>
    <tr>
      <td>Mitral stenosis</td>
      <td>Diastolic; low-pitched, decrescendo</td>
      <td>Apex (best heard in left lateral decubitus position)</td>
      <td>None</td>
      <td>Loud S‚ÇÅ; tapping apex beat; opening snap after S‚ÇÇ if leaflets mobile; irregular pulse if atrial fibrillation present</td>
      <td>Interval between S‚ÇÇ and opening snap is short in severe mitral stenosis. Intensity of murmur correlates with transvalvular gradient. P‚ÇÇ may be loud if pulmonary hypertension present</td>
    </tr>
    <tr>
      <td>Mitral regurgitation</td>
      <td>Systolic; holo-, mid-, or late systolic</td>
      <td>Apex</td>
      <td>Axilla or back; occasionally anteriorly to precordium</td>
      <td>Systolic click in mitral valve prolapse; S‚ÇÉ; apical impulse hyperdynamic and may be displaced if dilated left ventricle; in mitral valve prolapse, Valsalva maneuver moves onset of clicks and murmur closer to S‚ÇÅ; handgrip maneuver increases murmur intensity</td>
      <td>Acute severe regurgitation may have soft or no holosystolic murmur, mitral inflow rumble, or S‚ÇÉ</td>
    </tr>
    <tr>
      <td>Tricuspid regurgitation</td>
      <td>Holosystolic</td>
      <td>LLSB</td>
      <td>LUSB</td>
      <td>Merged and prominent c and v waves in jugular venous pulse; murmur increases during inspiration</td>
      <td>Right ventricular impulse below sternum. Pulsatile, enlarged liver with possible ascites. Murmur may be high-pitched if associated with severe pulmonary hypertension</td>
    </tr>
    <tr>
      <td>Tricuspid stenosis</td>
      <td>Diastolic; low-pitched, decrescendo; increased intensity during inspiration</td>
      <td>LLSB</td>
      <td>None</td>
      <td>Elevated central venous pressure with prominent a wave, signs of venous congestion (hepatomegaly, ascites, edema)</td>
      <td>Low-pitched frequency may be difficult to auscultate, especially at higher heart rate</td>
    </tr>
    <tr>
      <td>Pulmonary valve stenosis</td>
      <td>Systolic; crescendo-decrescendo</td>
      <td>LUSB</td>
      <td>Left clavicle</td>
      <td>Pulmonic ejection click after S‚ÇÅ (diminishes with inspiration)</td>
      <td>Increased intensity of murmur with late peaking</td>
    </tr>
    <tr>
      <td>Pulmonary valve regurgitation</td>
      <td>Diastolic; decrescendo</td>
      <td>LLSB</td>
      <td>None</td>
      <td>Loud P‚ÇÇ if pulmonary hypertension present</td>
      <td>Murmur may be minimal or absent if severe because of minimal difference in pulmonary artery and right ventricular diastolic pressures</td>
    </tr>
    <tr>
      <td>Benign (innocent) flow murmur</td>
      <td>Midsystolic; grade 1/6 or 2/6 in intensity</td>
      <td>RUSB</td>
      <td>None</td>
      <td>Normal intensity of A‚ÇÇ; normal splitting of S‚ÇÇ; no radiation</td>
      <td>May be present in conditions with increased flow (e.g., pregnancy, fever, anemia, hyperthyroidism)</td>
    </tr>
    <tr>
      <td>Hypertrophic obstructive cardiomyopathy</td>
      <td>Systolic; crescendo-decrescendo</td>
      <td>LLSB</td>
      <td>None</td>
      <td>Enlarged, hyperdynamic apical impulse; bifid carotid impulse with delay; increased intensity during Valsalva maneuver or with squatting to standing</td>
      <td>Murmur may not be present in nonobstructive hypertrophic cardiomyopathy</td>
    </tr>
    <tr>
      <td>Atrial septal defect</td>
      <td>Systolic; crescendo-decrescendo</td>
      <td>RUSB</td>
      <td>None</td>
      <td>Fixed split S‚ÇÇ; right ventricular heave; rarely, tricuspid inflow murmur</td>
      <td>May be associated with pulmonary hypertension with increased intensity of P‚ÇÇ, pulmonary valve regurgitation</td>
    </tr>
    <tr>
      <td>Ventricular septal defect</td>
      <td>Holosystolic</td>
      <td>LLSB</td>
      <td>None</td>
      <td>Palpable thrill; murmur increases with handgrip maneuver</td>
      <td>Murmur intensity and duration decrease as pulmonary hypertension develops (Eisenmenger syndrome). Cyanosis if Eisenmenger syndrome develops</td>
    </tr>
  </tbody>
</table>

<p><em>A‚ÇÇ = aortic component of S‚ÇÇ; LLSB = left lower sternal border; LUSB = left upper sternal border; P‚ÇÇ = pulmonic component of S‚ÇÇ; RLSB = right lower sternal border; RUSB = right upper sternal border.</em></p>